Business · 09/10/2026Updated: 10/17/2026 · 1 min read

European Medicines Agency Approves Modification to Paediatric Investigation Plan for Inaqovi, a Treatment for Blood and Lymphatic System Disorders

The European Medicines Agency has issued an opinion and decision on a modification to the Paediatric Investigation Plan (PIP) for Inaqovi, a treatment for blood and lymphatic system disorders, as requested by the manufacturer.